Regulations for the Manufacture and Control of Live Poliovirus Vaccine: International Experience and China’s Path  

作　　者：Miao Wu 

机构地区：[1]Institute for the History of Natural Sciences,Chinese Academy of Sciences,Beijing 100190,China

出　　处：《Chinese Medical Sciences Journal》2023年第4期315-320,共6页中国医学科学杂志（英文版）

基　　金：This work was supported by a key project of the 14th Five Year Plan of the Institute for the History of Natural Sciences,Chinese Academy of Sciences(E2291J01);the Youth Promotion Association of the Chinese Academy of Sciences(E3292G02).

摘　　要：The eradication of poliomyelitis is a landmark achievement in the history of public health, providing strong protection for children’s health. The introduction of the Chinese Regulations for the Manufacture and Control of Live Poliovirus Vaccine is a prerequisite and safeguard for the large-scale production and use of domestically produced live poliovirus vaccines, serving as an indispensable component of vaccine safety. This article, based on archival documents, letters, collections of essays, and oral interviews, examines the historical experience of the development of Chinese Regulations for the Manufacture and Control of Live Poliovirus Vaccine. It contends that the emphasis on localization and the active engagement in international cooperation are critical factors in the swift introduction of Chinese Regulations for the Manufacture and Control of Live Poliovirus Vaccine.

关 键 词：Chinese Regulations for the Manufacture and Control of Live Poliovirus Vaccine international cooperation localization Gu Fang Zhou 

分 类 号：R186[医药卫生—流行病学]